Biotechnology Stocks I Performance Guide: Ascendis Pharma A/S (ASND)
ASND has no dividends
Table and Chart of ASND Performance
See what a $1,000 investment in ASND is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ASND Returns | |
|---|---|
| Start Date | Feb-27-2015 |
| Start Price | $17.73 |
| End Date | Dec-01-2023 |
| End Price | $104.05 |
| # Prices | 107 |
| Min Date | Jun-30-2016 |
| Min Price | $13.27 |
| Max Date | Nov-30-2020 |
| Max Price | $168.73 |
| Total Return | 486.86% |
| Annualized Return | 21.95% |
| Current Value of $1,000 Purchase | $5,869 |
| Number Returns | 5,671 |
| Average Return | 210.16% |
| Number Profitable Returns | 4,458 |
| Percent Profitable Returns | 78.61% |
| Number Unprofitable Returns | 1,213 |
| Percent Unprofitable Returns | 21.39% |
| Profitable to Unprofitable Returns Ratio | 3.68 |
| ASND Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $5,883,726,000 | Price to Sales | 38.73 |
| Earnings per Share | $-11.6700 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 14.55 |
| PRICE DATA | |
| 52 Week High | $127.77 |
| 52 Week Low | $64.33 |
| Analyst Target Price | $0.34 |
| 50-Day Moving Average | $92.36 |
| 200-Day Moving Average | $93.8 |
| FINANCIAL DATA | |
| Revenue per Share | $2.706 |
| Revenue | $151,912,000 |
| Profit Margin | 0% |
| Return on Equity | -3.184% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ASND Compare Returns with S&P 500
ASND Trendline Chart